CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 82 enrolled
Drug / intervention
Protegera™ toothpaste (NaF) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06082869
NCT06082869Early Ph 1Completed
CompareCT.gov

Evaluation and Comparison of a Novel Dentrifice Formulation on Plaque Removal

Protegera, Inc.·interventional·Posted Oct 13, 2023·Updated Oct 13, 2023

In Brief

A Early Phase 1 clinical trial evaluating Protegera™ toothpaste (NaF) and Crest™ Cavity Protection toothpaste (NaF) for Dental Plaque. Completed, enrolled 82 participants across 1 site.

Detailed Summary

To evaluate and compare plaque removal efficacy and safety of a novel dentifrice formulation immediately after the first supervised use and following one week of twice, daily use at home.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Plaque
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
2023202420252026
First PostedOct 13, 2023
Enrollment StartJan 30, 2023
Primary CompletionFeb 23, 2023
TodayJul 2, 2026
Enrollment to primary: 23 daysPosted 2.7 years ago

Interventions

Protegera™ toothpaste (NaF)drug

Plaque Reduction

Crest™ Cavity Protection toothpaste (NaF)drug

Plaque Reduction